Skip to main content
Lisa Boggio, MD, Hematology, Chicago, IL, Rush University Medical Center

LisaBoggioMDMS

Hematology Chicago, IL

Hemophilia & Bleeding Disorder

Assistant Professor, Internal Medicine, Rush Medical College of Rush Univ

Dr. Boggio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Boggio's full profile

Already have an account?

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1999
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1993 - 1996
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1993

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1993 - 2026
  • American Board of Internal Medicine Hematology
  • National Board of Physicians and Surgeons Hematology
  • National Board of Physicians and Surgeons Internal Medicine
  • National Board of Physicians and Surgeons Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Red Blood Cell Exchange in Patients with Sickle Cell Disease—Indications and Management: A Review and Consensus Report by the Therapeutic Apheresis Subsection of the AABB  
    Mary Berg, Scott Koepsell, Angela Treml, Kelley E Capocelli, John Weiss, Geoffrey Wool, Beverly W Baron, Yong Zhao, Lisa Boggio, Elizabeth Biller, Huy P Pham, Transfusion

Lectures

  • Thrombotic Events with NovoSeven® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Identified Unmet Needs and Proposed Solutions in Mild‐to‐Moderate Haemophilia: A Summary of Opinions from a Roundtable of Haemophilia Experts
    Identified Unmet Needs and Proposed Solutions in Mild‐to‐Moderate Haemophilia: A Summary of Opinions from a Roundtable of Haemophilia ExpertsFebruary 1st, 2021

Hospital Affiliations